Not available
Quote | Alimera Sciences Inc. (NASDAQ:ALIM)
Last: | $3.485 |
---|---|
Change Percent: | 5.29% |
Open: | $3.28 |
Close: | $3.31 |
High: | $3.5 |
Low: | $3.28 |
Volume: | 13,723 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Alimera Sciences Inc. (NASDAQ:ALIM)
2024-03-20 11:40:23 ET More on iShares Russell 1000 Growth ETF, iShares Russell 2000 ETF, etc. IWF ETF: Solid Track Record, But Looks Overextended Now IWM: Are Small Caps Being Overlooked In The Megacap Market Frenzy? IWM: Super Micro Computer Is Leading The Russell ...
ATLANTA, March 20, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better...
Message Board Posts | Alimera Sciences Inc. (NASDAQ:ALIM)
Subject | By | Source | When |
---|---|---|---|
agreed | The Night Stalker | investorshub | 05/18/2023 2:32:25 PM |
$ALIM I got in for a play | MiamiGent | investorshub | 05/18/2023 1:45:59 PM |
Alimera Acquires U.S. Commercial Rights to YUTIQ | subslover | investorshub | 05/18/2023 12:24:59 PM |
$ALIM best news of the day | whytestocks | investorshub | 05/17/2023 10:09:44 PM |
is it bear time? Or do we go bull? | mick | investorshub | 05/17/2023 8:52:48 AM |
News, Short Squeeze, Breakout and More Instantly...
Alimera Sciences Inc. Company Name:
ALIM Stock Symbol:
NASDAQ Market:
Alimera Sciences Inc. Website:
ATLANTA, March 20, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better...
ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that th...